Evidence map›Paper›PMID 35679221›Full record

ArticleAmerican journal of respiratory cell and molecular biology2022

Intermediary Role of Lung Alveolar Type 1 Cells in Epithelial Repair upon Sendai Virus Infection.

Belinda J Hernandez, Margo P Cain, Anne M Lynch, Jose R Flores, Michael J Tuvim, Burton F Dickey, Jichao Chen

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. RelA Signaling inInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Article
  5. Advances in Single-Cell Sequencing for Infectious Diseases: Progress and Perspectives.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Cell Cross-Talk in Alveolar Microenvironment: From Lung Injury to Fibrosis.American journal of respiratory cell and molecular biology · 2024
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Alveolar epithelial regeneration in the aging lung.The Journal of clinical investigation · 2023
    Review
  16. Airway Mucus Dysfunction in COVID-19.American journal of respiratory and critical care medicine · 2022
    Article
  17. Review
  18. Alveolar Repair after Viral Injury: A Tale of Two Cell Types.American journal of respiratory cell and molecular biology · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Belinda J HernandezDepartment of Pulmonary Medicine, the University of Texas MD Anderson Cancer Center, Houston, Texas and.
Margo P CainDepartment of Pulmonary Medicine, the University of Texas MD Anderson Cancer Center, Houston, Texas and.
Anne M LynchDepartment of Pulmonary Medicine, the University of Texas MD Anderson Cancer Center, Houston, Texas and.
Jose R FloresDepartment of Pulmonary Medicine, the University of Texas MD Anderson Cancer Center, Houston, Texas and.
Michael J TuvimDepartment of Pulmonary Medicine, the University of Texas MD Anderson Cancer Center, Houston, Texas and.
Burton F DickeyDepartment of Pulmonary Medicine, the University of Texas MD Anderson Cancer Center, Houston, Texas and.ORCID 0000-0002-4780-1847
Jichao ChenDepartment of Pulmonary Medicine, the University of Texas MD Anderson Cancer Center, Houston, Texas and.
The University of Texas MD Anderson Cancer Center · US

Funding

Role of AT1 cells in perinatal lung maturationR01HL130129 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHEN, JICHAO · 2016 to 2023
$4.1M
Controlling the core airway mucin secretion machinery to prevent pathophysiologyR01HL129795 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DICKEY, BURTON F · 2015 to 2023
$3.8M
Transcriptional and epigenetic basis of lung epithelial cell fateR01HL153511 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHEN, JICHAO · 2020 to 2023
$2.5M
AP-1 as a transcriptional regulator of AT2 cell reversible activation during lung injury responseF31HL165914 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI LYNCH, ANNE · 2022 to 2024
$143k
NHLBI NIH HHS F31 HL165914NHLBI NIH HHS R01 HL129795NHLBI NIH HHS R01 HL130129NHLBI NIH HHS R01 HL153511
6 · The paper itself

Abstract

The lung epithelium forms the first barrier against respiratory pathogens and noxious chemicals; however, little is known about how more than 90% of this barrier, made of AT1 (alveolar type 1) cells, responds to injury. Using the Sendai virus to model natural infection in mice, we find evidence that AT1 cells have an intermediary role by persisting in areas depleted of AT2 cells, upregulating IFN responsive genes, and receding from invading airway cells. Sendai virus infection mobilizes airway cells to form alveolar SOX2

Indexed as

Alveolar Epithelial CellsRespirovirus InfectionsAnimalsCell DifferentiationCells, CulturedLungMiceAT1 cellslung viral injurysingle-cell RNA-seq

Identifiers

PMID35679221
PMCPMC9447132
OpenAlexW4281951949

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.